TABLE 1.
Sample Characteristics (N = 166) Characteristic n %
| Characteristic | n | % |
|---|---|---|
| Ethnicity | ||
| Non-Hispanic | 162 | 98 |
| Hispanic | 2 | 1 |
| Unknown | 2 | 1 |
| Marital status | ||
| Partnered | 123 | 74 |
| Non-partnered | 41 | 25 |
| Unknown | 2 | 1 |
| Employment status | ||
| Not employed | 103 | 62 |
| Full-time | 48 | 29 |
| Part-time | 13 | 8 |
| Unknown | 2 | 1 |
| Education | ||
| Some high school | 6 | 4 |
| High school graduate | 31 | 19 |
| Some college | 52 | 31 |
| Associate degree | 15 | 9 |
| Bachelor’s degree | 36 | 22 |
| Postgraduate | 22 | 13 |
| Unknown | 4 | 3 |
| Income ($) | ||
| Less than 9,999 | 8 | 5 |
| 10,000–29,999 | 16 | 10 |
| 30,000–49,999 | 37 | 22 |
| 50,000–69,999 | 20 | 12 |
| 70,000 or more | 57 | 34 |
| Unknown | 10 | 6 |
| Declined to state | 18 | 11 |
| Stage of disease | ||
| I | 20 | 12 |
| II | 67 | 40 |
| III | 38 | 23 |
| IV | 36 | 22 |
| Unknown | 5 | 3 |
| Chemotherapy regimen | ||
| Cyclophosphamide with doxorubicin | 68 | 41 |
| Docetaxel | 23 | 14 |
| Cyclophosphamide with methotrexate and 5-fluorouracil | 16 | 10 |
| Docetaxel and carboplatin | 13 | 8 |
| Cyclophosphamide with docetaxel | 12 | 7 |
| Cyclophosphamide with doxorubicin and docetaxel | 9 | 5 |
| Cyclophosphamide with doxorubicin and 5-fluorouracil | 6 | 4 |
| Cyclophosphamide with 5-fluorouracil | 4 | 2 |
| Other | 15 | 9 |
Note. Because of rounding, percentages may not total 100.